Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

Once again, Dupixent finished in second place with an impressions SOV of 5.40% and 2.8 billion impressions. Notably, the ...

2 Top Growth Stocks to Buy on the Dip was originally published by The Motley Fool ...

Dupixent is already approved in the US for a variety of indications, going back to eczema in 2017 (and most recently for the treatment of the rare skin condition prurigo nodularis), but its ...

Sanofi’s Dupixent has shown there is a market for biologic drugs to treat eczema, and now Spain’s Almirall wants a piece of the action. The company’s head of external innovation and ...

additional side effects from the COVID-19 vaccine for people with eczema. In one study, a handful of people who took Dupixent (dupilumab) by injection had an eczema flare after being vaccinated for ...

Taurasi has been taking Dupixent after working with her dermatologist. An estimated 2.7 million people in the U.S. ages 6 months and older have uncontrolled moderate-to-severe eczema. When she ...

NEW YORK, Nov. 13 (UPI) --Living in places with more air pollution raises the risk of eczema, a chronic condition that causes dry, itchy and inflamed skin, a new study suggests. The study was ...

Air pollution is increasingly being linked to a raised risk of eczema, with the latest study showing a clear relationship between exposure and the skin condition. Vehicles and power plants release ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.